Skip to main content
Fig. 4 | Journal of Hematology & Oncology

Fig. 4

From: Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation

Fig. 4

Overall survival according to IDH, IDH1 and IDH2 mutational status and allogeneic hematopoietic cell transplantation in CR1. Simon–Makuch plots for a overall survival and b relapse-free survival of AML patients with mutated (mut) IDH, IDH1 and IDH2 treated with allogeneic hematopoietic cell transplantation (blue) or conventional consolidation (red), respectively; p‐values were determined with Cox model with time‐dependent modeling of alloHCT; time in months; ns = not significant

Back to article page